Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genetic Analysis Launches GA-map Microarray Test
Genetic Analysis has launched GA-map microarray test for high throughput screening of infant gut microbiota. The company presented data from evaluation screens that show its potential as a
Genetic Analysis has launched GA-map microarray test for high throughput screening of infant gut microbiota. The company presented data from evaluation screens that show its potential as a
TriCore has evaluated Roche´s new Magna Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen
PPD (Pharmaceutical Product Development) has completed its acquisition of BioDuro. With this acquisition, PPD now employs more than 1,400 in Asia Pacific and nearly 1,000 people in China,
Daxor has reported that the Medical University of South Carolina (MUSC) in Charleston has purchased a blood volume analyzer BVA-100 to assist with the diagnosis and treatment of
Basf has started up a new plant complex for the production of the chemical intermediates cyclopentanone (CPon) and cyclododecanone (CDon) at its Ludwigshafen Verbund site on November 30,
Bavarian Nordic expects to file a New Drug Submission (NDS) for its smallpox vaccine, Imvamune with the Canadian Authorities, Health Canada in 2010. If successful, this would be
Cell Therapeutics has reported that its new class of platinum-based anti-tumor compounds, termed bis-platinates, demonstrated a stronger anti-tumor potency and activity compared to currently available platinum-based compounds as
Merck KGaA announced that its US affiliate received a refuse to file letter from the FDA on the New Drug Application (NDA) for Cladribine tablets, Merck Serono’s proprietary
Novavax has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age
Caire, which operates under Chart’s BioMedical segment, has completed the previously announced acquisition of Covidien’s oxygen therapy business, including the design, manufacturing, and sales and service functions worldwide.